Conversely, morin treatment led to a significant and dose-dependent suppression of the mRNA expression of IL-6, IL-1β, IL-18, and NLRP3 in LPS+ATP-induced NSCLC cells compared to in the LPS+ATP-stimulated group (p < 0.001) (Figure 8A,B) of NSCLC cells. The gene discussed is NLRP3; the disease is non-small cell lung carcinoma.